Fulcrum Therapeutics (FULC) Change in Intangibles (2019)
Fulcrum Therapeutics (FULC) reported Change in Intangibles of $91000.0 for Q1 2019.
Fulcrum Therapeutics (FULC) Change in Intangibles (2019) Analysis & Trends
Fulcrum Therapeutics (FULC) has 1 years of Change in Intangibles data on file, last reported at $91000.0 in Q1 2019.
- Change in Intangibles for Q1 2019 came in at $91000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $91000.0 (changed N/A YoY), and the FY2019 annual result was $91000.0, changed N/A from the prior year.
- Change in Intangibles held at $91000.0 in Q1 2019 per FULC's latest filing.
- Over five years, Change in Intangibles peaked at $91000.0 in Q1 2019 and troughed at $91000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Fulcrum Therapeutics | 267.90 Mn | 267.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 91,000.00 |
| Mar 31, 2019 | 91,000.00 |